| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |